KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) EBT Margin (2019 - 2026)

GoodRx Holdings' EBT Margin history spans 7 years, with the latest figure at 7.29% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 154.0% to 7.29% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.1%, a 312.0% increase, with the full-year FY2025 number at 7.1%, up 312.0% from a year prior.
  • EBT Margin hit 7.29% in Q4 2025 for GoodRx Holdings, up from 3.11% in the prior quarter.
  • Over the last five years, EBT Margin for GDRX hit a ceiling of 9.64% in Q2 2025 and a floor of 25.9% in Q3 2023.
  • Historically, EBT Margin has averaged 0.3% across 5 years, with a median of 2.35% in 2021.
  • The widest YoY moves for EBT Margin: up 20181bps in 2021, down -3311bps in 2021.
  • Tracing GDRX's EBT Margin over 5 years: stood at 2.75% in 2021, then plummeted by -194bps to 2.58% in 2022, then crashed by -386bps to 12.53% in 2023, then surged by 146bps to 5.75% in 2024, then increased by 27bps to 7.29% in 2025.
  • Business Quant data shows EBT Margin for GDRX at 7.29% in Q4 2025, 3.11% in Q3 2025, and 9.64% in Q2 2025.